Physician Assistant · Norman, OK
NPI
1366831455
Since 2015
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
1016 24th Ave NW Ste 110
Norman, OK, 73069
Phone (405) 467-2280
Medicare paid, 2024
$38K
1,144 services
Medicare patients, 2024
163
Average age 72
Drug cost, 2024
$1.7M
1,916 prescriptions
Company payments, 2025
$2,493
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie Porter was code 99214 (office e&m - established), 256 times for 146 patients. In total Stephanie Porter billed 1,144 services in 10 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 256 | 146 | $77.71 | $20K |
| 95251 Test - Miscellaneous | Office | 248 | 122 | $21.67 | $5,374 |
| 82962 Clinical Chemistry | Office | 194 | 141 | $3.18 | $616 |
| 83036 Blood Count | Office | 190 | 143 | $9.42 | $1,790 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 168 | 125 | $10.75 | $1,807 |
| 99215 Office E&M - Established | Office | 72 | 57 | $110.20 | $7,934 |
By year: 2022 $37K for 1,216 services; 2023 $37K for 1,215 services; 2024 $38K for 1,144 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 194 | 141 | $3.18 | $616 |
| 83036 Blood Count | 190 | 143 | $9.42 | $1,790 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie Porter prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 226 prescriptions and refills. In total Stephanie Porter wrote 1,916 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 226 | 384 | 53 | $409K |
| Ozempic Semaglutide | 156 | 316 | 45 | $307K |
| Metformin Hcl Er Metformin Hcl | 143 | 397 | 44 | $1,614 |
| Jardiance Empagliflozin | 94 | 211 | 20 | $121K |
| Tresiba Flextouch U-200 Insulin Degludec | 83 | 173 | 29 | $133K |
| Glipizide Er Glipizide | 72 | 209 | 25 | $1,186 |
| Metformin Hcl Generic | 67 | 201 | 23 | $813 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 60 | 147 | 24 | $5,809 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 56 | 134 | 14 | $116K |
| Farxiga Dapagliflozin Propanediol | 55 | 125 | 15 | $70K |
| Levothyroxine Sodium Generic | 53 | 136 | 15 | $310 |
| Lyumjev Kwikpen U-100 Insulin Lispro-Aabc | 44 | 74 | 16 | $31K |
| Glipizide Generic | 44 | 122 | 14 | $546 |
| Fiasp Insulin Aspart (Niacinamide) | 42 | 66 | Under 11 | $58K |
| Glimepiride Generic | 42 | 120 | 14 | $314 |
Brand drugs: 1,185 claims; generic drugs: 543 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephanie Porter $2,493 ($2,493 in general payments such as food, travel and fees) from 21 companies. The largest payer was Tandem Diabetes Care, Inc. with $1,526.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 5 | $1,526 |
| Novo Nordisk Inc NVO | 5 | $183 |
| Xeris Pharmaceuticals, Inc. | 6 | $116 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $106 |
| Beta Bionics, Inc. BBNX | 4 | $73.63 |
| Sequel Med Tech, LLC | 3 | $70.89 |
| Dexcom, Inc. DXCM | 3 | $63.22 |
| Abbott Laboratories ABT | 2 | $40.12 |
| Lilly USA, LLC LLY | 2 | $36.47 |
| Corcept Therapeutics CORT | 2 | $35.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.